Induction of ID2 expression by hypoxia-inducible factor-1: a role in dedifferentiation of hypoxic neuroblastoma cells - PubMed (original) (raw)

. 2004 Sep 17;279(38):39223-31.

doi: 10.1074/jbc.M402904200. Epub 2004 Jul 13.

Affiliations

• PMID: 15252039
• DOI: 10.1074/jbc.M402904200

Free article

Induction of ID2 expression by hypoxia-inducible factor-1: a role in dedifferentiation of hypoxic neuroblastoma cells

Tobias Löfstedt et al. J Biol Chem. 2004.

Free article

Abstract

ID (inhibitor of differentiation/DNA binding) proteins, frequently deregulated in advanced human malignancies, can participate in multiple fundamental traits of cancer, such as block of differentiation, increased proliferation, tissue invasiveness, and angiogenesis. We have previously demonstrated that hypoxia decreases expression of neuronal marker genes in neuroblastoma, but induces genes expressed in the neural crest, such as ID2. Because of its involvement in normal neural crest development and its ability to inhibit proneuronal bHLH proteins, the hypoxic induction of ID2 was of particular interest. Here we report fast induction kinetics of ID2 expression in hypoxic neuroblastoma cells. The up-regulation of ID2 was abolished by addition of actinomycin D, implicating a hypoxia-driven transcriptional mechanism. Analyzing the ID2 promoter revealed several potential binding sites for hypoxia-inducible factors. Subsequent electrophoretic mobility shift and chromatin immunoprecipitation assays demonstrated two functional HIF-1 binding sites within ID2 gene regulatory sequences located at -725 and -1893 relative to the transcriptional initiation point. In transfection assays, DNA constructs of the ID2 promoter, including the functional HIF-1 binding sites, induced luciferase reporter activity in a HIF-1-specific manner. These observations demonstrate that ID2 is actively engaged by hypoxia and represents a novel HIF-1 target. Hypoxia-induced ID2 expression could play a significant role in the previously observed dedifferentiation of hypoxic neuroblastoma cells, which in a clinical setting could lead to less mature and more aggressive tumors.

PubMed Disclaimer

Similar articles

• Cross-talk between hypoxic and circadian pathways: cooperative roles for hypoxia-inducible factor 1alpha and CLOCK in transcriptional activation of the vasopressin gene.
  Ghorbel MT, Coulson JM, Murphy D. Ghorbel MT, et al. Mol Cell Neurosci. 2003 Mar;22(3):396-404. doi: 10.1016/s1044-7431(02)00019-2. Mol Cell Neurosci. 2003. PMID: 12691740
• Id2 protein is selectively upregulated by UVB in primary, but not in immortalized human keratinocytes and inhibits differentiation.
  Simbulan-Rosenthal CM, Trabosh V, Velarde A, Chou FP, Daher A, Tenzin F, Tokino T, Rosenthal DS. Simbulan-Rosenthal CM, et al. Oncogene. 2005 Aug 18;24(35):5443-58. doi: 10.1038/sj.onc.1208709. Oncogene. 2005. PMID: 16007217
• Transcriptional up-regulation of inhibitory PAS domain protein gene expression by hypoxia-inducible factor 1 (HIF-1): a negative feedback regulatory circuit in HIF-1-mediated signaling in hypoxic cells.
  Makino Y, Uenishi R, Okamoto K, Isoe T, Hosono O, Tanaka H, Kanopka A, Poellinger L, Haneda M, Morimoto C. Makino Y, et al. J Biol Chem. 2007 May 11;282(19):14073-82. doi: 10.1074/jbc.M700732200. Epub 2007 Mar 12. J Biol Chem. 2007. PMID: 17355974
• Structural and functional analysis of hypoxia-inducible factor 1.
  Semenza GL, Agani F, Booth G, Forsythe J, Iyer N, Jiang BH, Leung S, Roe R, Wiener C, Yu A. Semenza GL, et al. Kidney Int. 1997 Feb;51(2):553-5. doi: 10.1038/ki.1997.77. Kidney Int. 1997. PMID: 9027737 Review.
• Hypoxia response and microRNAs: no longer two separate worlds.
  Ivan M, Harris AL, Martelli F, Kulshreshtha R. Ivan M, et al. J Cell Mol Med. 2008 Sep-Oct;12(5A):1426-31. doi: 10.1111/j.1582-4934.2008.00398.x. Epub 2008 Jul 8. J Cell Mol Med. 2008. PMID: 18624759 Free PMC article. Review.

Cited by

• Overexpression of Endogenous Retroviruses and Malignancy Markers in Neuroblastoma Cell Lines by Medium-Induced Microenvironmental Changes.
  Wieland L, Engel K, Volkmer I, Krüger A, Posern G, Kornhuber ME, Staege MS, Emmer A. Wieland L, et al. Front Oncol. 2021 May 7;11:637522. doi: 10.3389/fonc.2021.637522. eCollection 2021. Front Oncol. 2021. PMID: 34026614 Free PMC article.
• REST is a hypoxia-responsive transcriptional repressor.
  Cavadas MA, Mesnieres M, Crifo B, Manresa MC, Selfridge AC, Keogh CE, Fabian Z, Scholz CC, Nolan KA, Rocha LM, Tambuwala MM, Brown S, Wdowicz A, Corbett D, Murphy KJ, Godson C, Cummins EP, Taylor CT, Cheong A. Cavadas MA, et al. Sci Rep. 2016 Aug 17;6:31355. doi: 10.1038/srep31355. Sci Rep. 2016. PMID: 27531581 Free PMC article.
• Hypoxic conditions induce a cancer-like phenotype in human breast epithelial cells.
  Vaapil M, Helczynska K, Villadsen R, Petersen OW, Johansson E, Beckman S, Larsson C, Påhlman S, Jögi A. Vaapil M, et al. PLoS One. 2012;7(9):e46543. doi: 10.1371/journal.pone.0046543. Epub 2012 Sep 28. PLoS One. 2012. PMID: 23029547 Free PMC article.
• HIF-1 activation induces doxorubicin resistance in MCF7 3-D spheroids via P-glycoprotein expression: a potential model of the chemo-resistance of invasive micropapillary carcinoma of the breast.
  Doublier S, Belisario DC, Polimeni M, Annaratone L, Riganti C, Allia E, Ghigo D, Bosia A, Sapino A. Doublier S, et al. BMC Cancer. 2012 Jan 4;12:4. doi: 10.1186/1471-2407-12-4. BMC Cancer. 2012. PMID: 22217342 Free PMC article.
• Expression of the RNA-binding protein RBM3 is associated with a favourable prognosis and cisplatin sensitivity in epithelial ovarian cancer.
  Ehlén A, Brennan DJ, Nodin B, O'Connor DP, Eberhard J, Alvarado-Kristensson M, Jeffrey IB, Manjer J, Brändstedt J, Uhlén M, Pontén F, Jirström K. Ehlén A, et al. J Transl Med. 2010 Aug 20;8:78. doi: 10.1186/1479-5876-8-78. J Transl Med. 2010. PMID: 20727170 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations Database